Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Non-Muscle Invasive Recurrence and Management During Surveillance in Patients with Muscle-Invasive Bladder Cancer Who Achieve Clinical Complete Response to Neoadjuvant Chemotherapy.
Journal: The Journal of urology
Published: August 26, 2026
Should Metastatic Site Inform First-Line Therapy in Clear Cell Renal Cell Carcinoma?
Journal: Targeted oncology
Published: April 20, 2026
Clinical management of oligoprogressive renal cell carcinoma.
Journal: Expert review of anticancer therapy
Published: April 14, 2026
Corrigendum to "Safety and clinical activity of BMS-986365 (CC-94676), a dual androgen receptor ligand-directed degrader and antagonist, in heavily pretreated patients with metastatic castration-resistant prostate cancer": [Ann Oncol 36 (2025) 76-88].
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 08, 2026
Corrigendum to "Safety and clinical activity of BMS-986365 (CC-94676), a dual androgen receptor ligand-directed degrader and antagonist, in heavily pretreated patients with metastatic castration-resistant prostate cancer": [Ann Oncol 36 (2025) 76-88].
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 08, 2026
Positive Psychology Interventions in Patients With Prostate Cancer: A Systematic Review.
Journal: Cancer reports (Hoboken, N.J.)
Published: October 25, 2025
Association between medication burden and acute care use in older metastatic prostate cancer patients on androgen receptor signaling inhibitors.
Journal: Cancer
Published: September 05, 2025
Erratum: Diabetes and Acute Care Use Among Patients With Metastatic Prostate Cancer Treated With Androgen Receptor Signaling Inhibitors.
Journal: JCO oncology practice
Published: September 03, 2025
Second-Line Systemic Therapies in Metastatic Renal Cell Carcinoma: Current Insights and Future Directions.
Journal: Journal of cancer immunology
Published: July 15, 2025
Diabetes and Acute Care Use Among Patients With Metastatic Prostate Cancer Treated With Androgen Receptor Signaling Inhibitors.
Journal: JCO oncology practice
Published: June 12, 2025
Novel Strategies and Therapeutic Advances for Bladder Cancer.
Journal: Cancers
Published: May 27, 2025
Neoadjuvant Fc-enhanced anti-CTLA-4 targets Tregs to augment androgen deprivation in high-risk prostate cancer: A randomized phase I trial.
Journal: Cell reports. Medicine
Published: April 14, 2025
Last Updated: 09/26/2026